Clinical Trials in Transition: What Investigators Need to Know About GCP E6(R3) and Health Canada’s Modernization Agenda

Clinical research is changing rapidly. Updated guidelines for good clinical practice (GCP E6-R3), Health Canada's clinical trial modernization initiatives, and the emergence of decentralized trial models are reshaping expectations for investigator oversight, participant safety, and study operations.

Join us for a practical and engaging session designed for Sponsor-Investigators, and site Investigators. Through real-world examples and case studies, we'll explore what these changes mean for your site, your participants, and your responsibilities as an investigator.

Topics include:

• What GCP E6(R3) means in practice
• Health Canada's modernization agenda
• Decentralized and hybrid clinical trial models
• Oversight and delegation in a distributed trial environment
• Inspection readiness for the future
• Local supports, tools and templates for site Investigators and Sponsor-Investigators

Walk away with actionable strategies you can implement immediately to prepare your site for the evolving clinical research landscape.

This event is remote only. The same session will be offered at different times on October 14 and October 15 to accommodate varying schedules. A recording of one of these sessions will be made available for future reference and training.
Register for this event
Presented by
Tracie Hanna - Associate Director, Research Compliance and Training, Queen's University
Lisa McAvoy - Associate Director, Health Sciences Research, Kingston Health Sciences Centre Research Institute

For questions, please email  researchcompliance@queensu.ca